Noninvasive Aesthetic Treatment Market To Reach US$ 150.6 BN By 2030

Advancements in plastic surgery have led to the development of several non-invasive treatments to reduce or remove stubborn pockets of fat and contour and reshape different areas of the body safely and effectively. Some popular non-invasive aesthetic treatment options include Inmode EVOLVE treatment in NYC, BodyFx, Liposonix, and more.

According to Precedence Research, the global non-invasive aesthetic treatment market, which was valued at US$ 52.57 billion in 2021, is expected to reach over US$ 150.6 billion by 2030.  The market is predicted to garner growth at a CAGR of 12.4% from 2021 to 2030.

Factors Driving Growth in the Global Non-Invasive Aesthetic Treatment Market

The global non-invasive aesthetic treatment market is driven by factors such as

• increasing focus on the physical appearance among the young population
• growing geriatric population and increase in beauty consciousness
• rising popularity of the nonsurgical treatments
• rising demand for the skin aging treatments among the aging population
• desire to conceal the signs of aging
• rising disposable income and growing awareness about aesthetic treatments
• technological advancements and research and development in the cosmetic surgeries industry

The market is divided in to 3 segments – Product, End Use, and Region

By product, the market is divided in to Injectable (Polymer Filler, Collagen, Botulinum Toxin, Hyaluronic Acid, Calcium Hydroxylapatite), Skin Rejuvenation (Laser Skin Resurfacing, Chemical Peel, Photo-rejuvenation), and Others (Hair Removal, Sclerotherapy, Non-surgical Fat reduction, Cellulite Treatment).

The injectable segment dominated the global noninvasive aesthetic treatment market, accounting for over 60% of the market share in 2020. Its adoption among the consumers has increased mainly due to easy procedure, quick results, and less hassle associated with the injectables. Injectables are considered one of the best options to conceal the signs of aging. The injectables boost collagen production in skin, treat wrinkles and facial lines, and smooth the skin. These essential skin benefits have increased the demand for the injectables across the globe and led to the dominance of this segment. The others segments are also expected to grow at a rapid rate, owing to the rising adoption of the laser hair removal and nonsurgical fat reduction treatments, and the low cost availability of such treatments.

End users of this market include Hospitals & Surgery Centers, Medical Spa, Traditional Spa, HCP Owned Clinic, and Others. Factors such as the rising number of medical spas and the growth in the number of cosmetic physicians have fueled the growth of the medical spa segment, which dominated the market with a market share of around 40% in 2020. The availability of advanced treatments like laser treatments, skin rejuvenation, facial injections, and body contouring gives the serves the various needs of the consumers. Moreover, experienced professionals prescribe and provide proper advice regarding skin care. Moreover, the compliance of medical spas with the regulatory norms boosts public confidence.

Geographically, the market is divided in to North America (U.S., Canada, Mexico), Europe (U.K., Germany, France), Asia Pacific (China, India, Japan, South Korea), Latin America (Brazil, Rest of Latin America), Middle East & Africa (MEA) (GCC, North Africa, South Africa, Rest of Middle East & Africa). North America accounted for over 36% of the market share and dominated the market in 2020, mainly due to the increased awareness among the population regarding the non-invasive aesthetic treatments, high disposable income, rapidly aging population, and increased focus on the aesthetic appearances in the U.S. The higher adoption of the advanced treatment along with the presence of adequate number of efficient plastic surgeons has also contributed towards the market growth.

Asia Pacific is predicted to be the most opportunistic market during the forecast period. Prominent factors expected to drive the growth of this market in the foreseeable future are – the presence of huge youth population, rapidly growing geriatric people in the region, the rising disposable income, the improving gender ratio, improvement in the standard of living, rising focus of the consumers towards the aesthetic appearances and rising awareness regarding the availability of various non-invasive aesthetic treatments.

The report lists the leading market players as Galderma S.A., Allergen, El. En. SpA, Alma Lasers, Johnson & Johnson, Cynosure, Solta Medical, Syneron Candela, Lumenis, and Merz Pharma.  These market players adopt various developmental strategies like new product launches, acquisitions, partnerships, and mergers to gain competitive advantage over competitors.